Literature DB >> 12515253

Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer.

Nicola J Camp, Sean V Tavtigian.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12515253      PMCID： PMC378598          DOI： 10.1086/344516

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN： 0002-9297            Impact factor:   11.025


× No keyword cloud information.
  7 in total

1.  Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls.

Authors:  B K Suarez; D S Gerhard; J Lin; B Haberer; L Nguyen; N K Kesterson; W J Catalona
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

2.  Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.

Authors:  J Xu; S L Zheng; J D Carpten; N N Nupponen; C M Robbins; J Mestre; T Y Moses; D A Faith; B D Kelly; S D Isaacs; K E Wiley; C M Ewing; P Bujnovszky; B Chang ; J Bailey-Wilson; E R Bleecker; P C Walsh; J M Trent; D A Meyers; W B Isaacs
Journal:  Am J Hum Genet       Date:  2001-03-14       Impact factor: 11.025

3.  HPC2 variants and screen-detected prostate cancer.

Authors:  D Vesprini; R K Nam; J Trachtenberg; M A Jewett; S V Tavtigian; M Emami; M Ho; A Toi; S A Narod
Journal:  Am J Hum Genet       Date:  2001-03-14       Impact factor: 11.025

4.  Role of HPC2/ELAC2 in hereditary prostate cancer.

Authors:  L Wang; S K McDonnell; D A Elkins; S L Slager; E Christensen; A F Marks; J M Cunningham; B J Peterson; S J Jacobsen; J R Cerhan; M L Blute; D J Schaid; S N Thibodeau
Journal:  Cancer Res       Date:  2001-09-01       Impact factor: 12.701

5.  Association of HPC2/ELAC2 genotypes and prostate cancer.

Authors:  T R Rebbeck; A H Walker; C Zeigler-Johnson; S Weisburg; A M Martin; K L Nathanson; A J Wein; S B Malkowicz
Journal:  Am J Hum Genet       Date:  2000-09-12       Impact factor: 11.025

6.  ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.

Authors:  A Rökman; T Ikonen; N Mononen; V Autio; M P Matikainen; P A Koivisto; T L Tammela; O P Kallioniemi; J Schleutker
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

7.  A candidate prostate cancer susceptibility gene at chromosome 17p.

Authors:  S V Tavtigian; J Simard; D H Teng; V Abtin; M Baumgard; A Beck; N J Camp; A R Carillo; Y Chen; P Dayananth; M Desrochers; M Dumont; J M Farnham; D Frank; C Frye; S Ghaffari; J S Gupte; R Hu; D Iliev; T Janecki; E N Kort; K E Laity; A Leavitt; G Leblanc; J McArthur-Morrison; A Pederson; B Penn; K T Peterson; J E Reid; S Richards; M Schroeder; R Smith; S C Snyder; B Swedlund; J Swensen; A Thomas; M Tranchant; A M Woodland; F Labrie; M H Skolnick; S Neuhausen; J Rommens; L A Cannon-Albright
Journal:  Nat Genet       Date:  2001-02       Impact factor: 38.330
  7 in total
  14 in total

1.  Graphical modeling of the joint distribution of alleles at associated loci.

Authors:  Alun Thomas; Nicola J Camp
Journal:  Am J Hum Genet       Date:  2004-04-26       Impact factor: 11.025

Review 2.  The use of zebrafish model in prostate cancer therapeutic development and discovery.

Authors:  Haneen Amawi; Alaa A A Aljabali; Sai H S Boddu; Sadam Amawi; Mohammad A Obeid; Charles R Ashby; Amit K Tiwari
Journal:  Cancer Chemother Pharmacol       Date:  2021-01-03       Impact factor: 3.333

3.  Snm1-deficient mice exhibit accelerated tumorigenesis and susceptibility to infection.

Authors:  Shamima Ahkter; Christopher T Richie; Nianxiang Zhang; Richard R Behringer; Chengming Zhu; Randy J Legerski
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

4.  Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.

Authors:  Joke Beuten; Jonathan A L Gelfond; Jennifer L Franke; Stacey Shook; Teresa L Johnson-Pais; Ian M Thompson; Robin J Leach
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01-19       Impact factor: 4.254

5.  ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies.

Authors:  B Xu; N Tong; J-m Li; Z-d Zhang; H-f Wu
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-03-16       Impact factor: 5.554

6.  Identification of a prostate cancer susceptibility gene on chromosome 5p13q12 associated with risk of both familial and sporadic disease.

Authors:  Liesel M FitzGerald; Briony Patterson; Russell Thomson; Andrea Polanowski; Stephen Quinn; Jesper Brohede; Timothy Thornton; David Challis; David A Mackey; Terence Dwyer; Simon Foote; Garry N Hannan; James Stankovich; James D McKay; Joanne L Dickinson
Journal:  Eur J Hum Genet       Date:  2008-10-01       Impact factor: 4.246

7.  Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study.

Authors:  Yen-Ching Chen; Edward Giovannucci; Peter Kraft; David J Hunter
Journal:  Carcinogenesis       Date:  2008-03-28       Impact factor: 4.944

Review 8.  Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes.

Authors:  Charnita M Zeigler-Johnson; Elaine Spangler; Mohamed Jalloh; Serigne M Gueye; Hanna Rennert; Timothy R Rebbeck
Journal:  Can J Urol       Date:  2008-02       Impact factor: 1.344

Review 9.  Inherited predisposition to prostate cancer.

Authors:  Bas A J Verhage; Lambertus A L M Kiemeney
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 10.  Genetic polymorphisms and prostate cancer risk.

Authors:  Andrea Gsur; Elisabeth Feik; Stephan Madersbacher
Journal:  World J Urol       Date:  2003-11-26       Impact factor: 4.226
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.